title: Prolonged mitotic arrest triggers partial activation of apoptosis, resulting in DNA damage and p53 induction.
abstract: Mitotic arrest induced by antimitotic drugs can cause apoptosis or p53-dependent cell cycle arrest. It can also cause DNA damage, but the relationship between these events has been unclear. Live, single-cell imaging in human cancer cells responding to an antimitotic kinesin-5 inhibitor and additional antimitotic drugs revealed strong induction of p53 after cells slipped from prolonged mitotic arrest into G1. We investigated the cause of this induction. We detected DNA damage late in mitotic arrest and also after slippage. This damage was inhibited by treatment with caspase inhibitors and by stable expression of mutant, noncleavable inhibitor of caspase-activated DNase, which prevents activation of the apoptosis-associated nuclease caspase-activated DNase (CAD). These treatments also inhibited induction of p53 after slippage from prolonged arrest. DNA damage was not due to full apoptosis, since most cytochrome C was still sequestered in mitochondria when damage occurred. We conclude that prolonged mitotic arrest partially activates the apoptotic pathway. This partly activates CAD, causing limited DNA damage and p53 induction after slippage. Increased DNA damage via caspases and CAD may be an important aspect of antimitotic drug action. More speculatively, partial activation of CAD may explain the DNA-damaging effects of diverse cellular stresses that do not immediately trigger apoptosis.
authors.affiliation: Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA. james_orth@hms.harvard.edu
authors.forename: James D
authors.initials: JD
authors.lastname: Orth
authors.forename: Alexander
authors.initials: A
authors.lastname: Loewer
authors.forename: Galit
authors.initials: G
authors.lastname: Lahav
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Mitchison
mesh_terms: D050256:Antimitotic Agents / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D059447:Cell Cycle Checkpoints / Q000502:physiology*; D045744:Cell Line, Tumor; D004249:DNA Damage / Q000502:physiology*; D003851:Deoxyribonucleases / Q000096:biosynthesis; D006801:Humans; D016547:Kinesins / Q000037:antagonists & inhibitors; D008938:Mitosis / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D011804:Quinolines / Q000494:pharmacology; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
chemical_list: D050256:Antimitotic Agents; C561944:EMD 534085; D011804:Quinolines; D016159:Tumor Suppressor Protein p53; D003851:Deoxyribonucleases; C109663:caspase-activated deoxyribonuclease; D016547:Kinesins